Skip to main content

Table 1 Pathogen distribution of late-onset infection events

From: GloveCare: a pilot study in preparation for a cluster crossover randomized controlled trial of non-sterile glove-based care in preventing late-onset infection in the NICU

Number of primary late-onset infection events and mortality

GloveCare arm

N=63

Standard arm

N=48

P-value (chi-square test)

Sterile site infections,n (%)

 Any sterile site infection (culture positive meningitis, bacteremia, urinary tract infection)

14 (22.2)

15 (31.3)

0.284

  Gram positive

9

7

0.965

  Gram negative

9

5

0.264

 Meningitis (n (%))

3 (4.8)

0 (0.0)

0.257 (FE)

  Gram-positive

2 (66.7)

  

  Gram-negative

1 (33.3)

  

  Mean duration of antibiotic therapy (SD)

29.33 (16.4)

  

  Mean C-reactive protein (CRP, mg/L) (SD)

124.25 (72.1)

  

 Bacteremia (n (%))

4 (6.3)

6 (12.5)

0.324 (FE)

  Gram-positive

3 (75.0)

0 (0.0)

0.257 (FE)

  Gram-negative

1 (25.0)

5 (83.3)

0.0831 (FE)

  Candida

0 (0.0)

1 (16.7)

 

  Mean duration of antibiotic therapy (SD)

14.25 (9.4)

30.50 (26.5)

 

  Mean C-reactive protein (CRP, mg/L) (SD)

81.05 (81.7)

139.42 (177.0)

 

 Urinary Tract Infection (n (%))

7 (11.1)

9 (18.8)

0.256 (CS)

  Gram-positive

4 (57.1)

7 (77.8)

0.203 (FE)

  Gram-negative

3 (42.9)

2 (28.6)

1.00 (FE)

  Mean duration of antibiotic therapy (SD)

9.29 (3.6)

14.44 (12.3)

 

  Mean C-reactive protein (CRP, mg/L) (SD)

17.36 (15.7)

21.70 (14.3)

 

Nonsterile site infections,n (%)

 Secondary infection outcomes

49 (77.8)

33 (68.8)

0.284

 Culture negative meningitis

3 (4.8)

0 (0.0)

0.257

  Mean duration of antibiotic therapy (SD)

26.67 (16.3)

  

  Mean C-reactive protein (CRP, mg/L) (SD)

30.67 (39.2)

  

 Single positive CONS blood culture (n (%))

11 (17.5)

4 (8.3)

0.164

  Mean duration of antibiotic therapy (SD)

9.27 (3.3)

10.50 (4.8)

 

  Mean C-reactive protein (CRP, mg/L) (SD)

41.42(47.6)

15.07 (24.1)

 

 Abdominal infection (n (%))

4 (6.3)

7 (14.6)

0.203

  Mean duration of antibiotic therapy (SD)

14.75 (9.0)

9.86 (5.2)

 

  Mean C-reactive protein (CRP, mg/L) (SD)

114.00 (91.5)

68.91 (93.9)

 

 Pneumonia (n (%))

9 (14.3)

6 (12.5)

0.785

  Mean duration of antibiotic therapy (SD)

9.89 (1.8)

10.67 (6.1)

 

  Mean C-reactive protein (CRP, mg/L) (SD)

34.28 (23.0)

47.15 (55.1)

 

 Cellulitis (n (%))

2 (3.2)

0 (0.0)

0.505

  Mean duration of antibiotic therapy (SD)

9 (1.4)

  

  Mean C-reactive protein (CRP, mg/L) (SD)

51.60 (17.7)

  

 Culture negative sepsis (n (%))

20 (31.7)

16 (33.3)

0.860

  Mean duration of antibiotic therapy (SD)

8.30 (3.4)

8.75 (2.8)

 

  Mean C-reactive protein (CRP, mg/L) (SD)

52.04 (43.3)

47.87 (76.6)

 

 Time to first infection, among all patients with infection, days (n=75), mean (sd)

(“Removing” time in additional precautions)

20.1 (16.1)

11.4 (8.3)

0.004

  1. FE Fisher’s exact test used instead of chi-square